Ocean Biomedical, Inc. (OCEAW) Comparison with companies in other sectors?

Ocean Biomedical, Inc. has a share price of 504.20M. You can analyze Ocean Biomedical, Inc. (OCEAW) competitors across different market sectors through stock heatmaps.

What are OCEAW's NET and operating margins?

Ocean Biomedical, Inc. (OCEAW) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does OCEAW's earnings per share (EPS) trend reflect its financial momentum?

Ocean Biomedical, Inc. (OCEAW) EPS is N/A (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Ocean Biomedical, Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Ocean Biomedical, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Ocean Biomedical, Inc. like P/E which is -0.14, P/B which is -0.04, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Ocean Biomedical, Inc.

OCEAW•NASDAQ

Healthcare

Biotechnology

$0.003

$-0.00(-63.38%)

Fundamental Analysis of Ocean Biomedical, Inc. (OCEAW)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

P/E Ratio

ROE

0.26%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$692.40K

Shares OutstandingTotal number of shares issued

$504.20M

Book Value/ShareNet worth per share

$-1.02

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

25.77%

ROAReturn on total assets

-1551.20%

ROCEReturn on capital employed

16.65%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.04

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

-92.29%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for OCEAWFinancial Ratios Analysis details for OCEAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for OCEAWSector Benchmarking details for OCEAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Ocean Biomedical, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Ocean Biomedical, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Ocean Biomedical, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Ocean Biomedical, Inc.

For Ocean Biomedical, Inc., essential financial indicators include EPS -, PE -, and ROE 0.26. These key ratios reveal insights into Ocean Biomedical, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Ocean Biomedical, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Ocean Biomedical, Inc.

Metrics like Net Margin - and ROA -1551.20% shed light on how well Ocean Biomedical, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Ocean Biomedical, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Ocean Biomedical, Inc.

Using ratios such as P/B Ratio -0.04 and PEG Ratio 0.00, investors can assess whether Ocean Biomedical, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Ocean Biomedical, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Ocean Biomedical, Inc.

Financial health indicators, such as Debt/Equity Ratio -0.10 and Cash Flow $-0.04, provide a snapshot of Ocean Biomedical, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Ocean Biomedical, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Ocean Biomedical, Inc.

Investing in Ocean Biomedical, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Ocean Biomedical, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;